Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jiejing Yin"'
Autor:
Jiejing Yin, Yekaterina Belogrivtseva, Ahmed Lazim, Samir Amer, Dina Zenezan, Riya Kuklani, Daniela Proca
Publikováno v:
Human Pathology Reports, Vol 37, Iss , Pp 300748- (2024)
Background: Cemento-ossifying fibroma (COF) and focal cemento-osseous dysplasia (FCOD) are benign neoplasms occurring in the mandible and maxilla; histologically, they both show normal bone replacement by a fibrous stroma containing variable amounts
Externí odkaz:
https://doaj.org/article/29a48212fd304a7b9ef7e09b607bef3d
Publikováno v:
American Journal of Case Reports. 3/4/2024, Vol. 25, p1-8. 8p.
Autor:
Yibin Yang, Thomas A. Waldmann, Michael Petrus, Stefan K. Barta, Yan Zhou, Jiejing Yin, Liqi Chen, Wenming Xiao, Zhihui Song, Yuquan Lin, Wei Wei
Purpose:For patients with refractory/relapsed Hodgkin lymphoma (roughly 20% of total cases), few effective therapeutic options exist. Currently, brentuximab vedotin (BV), a drug-conjugated anti-CD30 antibody, is one of the most effective approved the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6746de6ec11411851df1992fe4d9dd20
https://doi.org/10.1158/1078-0432.c.6529194.v1
https://doi.org/10.1158/1078-0432.c.6529194.v1
Autor:
Yibin Yang, Thomas A. Waldmann, Michael Petrus, Stefan K. Barta, Yan Zhou, Jiejing Yin, Liqi Chen, Wenming Xiao, Zhihui Song, Yuquan Lin, Wei Wei
Supplementary Information. Including Supplemental Experimental Procedures, and Supplementary Figure 1-6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08f2e4a31ae632ac036e7be0da2459d
https://doi.org/10.1158/1078-0432.22475844.v1
https://doi.org/10.1158/1078-0432.22475844.v1
Autor:
Zhihui Song, Joseph Fabrizio, Jiejing Yin, Wei Wei, Yibin Yang, Essel Dulaimi Al-Saleem, Liqi Chen, Michael N. Petrus, Thomas A. Waldmann, Reza Nejati, Wenming Xiao
Publikováno v:
Proc Natl Acad Sci U S A
More than 70% of Epstein-Barr virus (EBV)-negative Hodgkin lymphoma (HL) cases display inactivation of TNFAIP3 (A20), a ubiquitin-editing protein that regulates nonproteolytic protein ubiquitination, indicating the significance of protein ubiquitinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e783b909e262bf57af184d9319ae25a
https://europepmc.org/articles/PMC7682429/
https://europepmc.org/articles/PMC7682429/
Autor:
Liqi Chen, Wenming Xiao, Yan Zhou, Yibin Yang, Wei Wei, Michael N. Petrus, Thomas A. Waldmann, Jiejing Yin, Stefan K. Barta, Yuquan Lin, Zhihui Song
Publikováno v:
Clin Cancer Res
Purpose: For patients with refractory/relapsed Hodgkin lymphoma (roughly 20% of total cases), few effective therapeutic options exist. Currently, brentuximab vedotin (BV), a drug-conjugated anti-CD30 antibody, is one of the most effective approved th
Autor:
Ginette Schiby, Atar Lev, Ninette Amariglio, Yibin Yang, Minshi Wang, Yu Nee Lee, Michele Rhodes, Yong Zhang, Iris Barshack, Gideon Rechavi, Raz Somech, David L. Wiest, Amos J. Simon, Ben Zion Garty, Jerry Stein, Ortal Barel, Jennifer Rhodes, Jiejing Yin, Camila Avivi, Nufar Marcus
Regulation of the actin cytoskeleton is crucial for normal development and function of the immune system, as evidenced by the severe immune abnormalities exhibited by patients bearing inactivating mutations in the Wiskott–Aldrich syndrome protein (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a749ca22609a57172d5b5e553f6df75
https://europepmc.org/articles/PMC5726601/
https://europepmc.org/articles/PMC5726601/
Autor:
Somech, Raz1,2, Lev, Atar1,2, Yu Nee Lee1,2, Simon, Amos J.1,2,3, Barel, Ortal2,4, Schiby, Ginette5, Avivi, Camila5, Barshack, Iris5, Rhodes, Michele6, Jiejing Yin6, Minshi Wang6, Yibin Yang6, Rhodes, Jennifer6, Marcus, Nufar7, Garty, Ben-Zion7, Stein, Jerry8, Amariglio, Ninette1,2,4,9, Rechavi, Gideon1,4, Wiest, David L.6 david.wiest@fccc.edu, Yong Zhang6 yong.zhang@fccc.edu
Publikováno v:
Journal of Immunology. 12/15/2017, Vol. 199 Issue 12, p4036-4045. 10p.